Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-22

Clinical Trial Update: Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing the 3D regimen versus G/P for treatment of acute hepatitis C; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 3D regimen
  • G/P (glecaprevir/pibrentasvir)

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C, Acute | Phase 3 | Status: COMPLETED